HTA Barriers for Conditional Approval Drugs
HTA Barriers for Conditional Approval Drugs
About this item
Full title
Author / Creator
Publisher
Cham: Springer International Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
Background
Conditional approval pathways facilitate accelerated marketing authorisation based on immature clinical evidence for drugs that address an unmet medical need in a life-threatening or chronically debilitating condition. Lowering evidence requirements for marketing authorisation results in higher clinical uncertainty, which may present...
Alternative Titles
Full title
HTA Barriers for Conditional Approval Drugs
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2779345329
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2779345329
Other Identifiers
ISSN
1170-7690
E-ISSN
1179-2027
DOI
10.1007/s40273-023-01248-9
